Insufficient scRNA-seq data for expression of AARS2 at single-cell level.
Insufficient scRNA-seq data for expression of AARS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1151.73 | 1445 / 1445 | 100% | 19.37 | 183 / 183 |
| prostate | 100% | 1556.42 | 245 / 245 | 100% | 18.83 | 502 / 502 |
| skin | 100% | 1326.40 | 1809 / 1809 | 100% | 36.38 | 472 / 472 |
| uterus | 100% | 1510.60 | 170 / 170 | 100% | 21.11 | 459 / 459 |
| breast | 100% | 1086.80 | 459 / 459 | 100% | 16.57 | 1117 / 1118 |
| thymus | 100% | 1379.89 | 653 / 653 | 100% | 14.26 | 604 / 605 |
| intestine | 100% | 1174.26 | 966 / 966 | 100% | 16.71 | 526 / 527 |
| liver | 100% | 755.25 | 226 / 226 | 100% | 13.52 | 405 / 406 |
| bladder | 100% | 1143.76 | 21 / 21 | 100% | 17.56 | 502 / 504 |
| kidney | 100% | 975.12 | 89 / 89 | 100% | 15.31 | 897 / 901 |
| ovary | 100% | 1614.88 | 180 / 180 | 100% | 14.29 | 428 / 430 |
| brain | 100% | 1082.71 | 2629 / 2642 | 100% | 16.73 | 704 / 705 |
| stomach | 100% | 872.16 | 359 / 359 | 99% | 16.32 | 284 / 286 |
| pancreas | 100% | 740.63 | 327 / 328 | 99% | 12.34 | 177 / 178 |
| lung | 99% | 932.20 | 574 / 578 | 100% | 16.14 | 1152 / 1155 |
| adrenal gland | 100% | 1016.94 | 258 / 258 | 99% | 13.85 | 227 / 230 |
| eye | 0% | 0 | 0 / 0 | 100% | 27.73 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.66 | 29 / 29 |
| spleen | 100% | 1510.51 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 19.35 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.51 | 1 / 1 |
| adipose | 100% | 906.63 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 592.86 | 1323 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 741.03 | 850 / 861 | 0% | 0 | 0 / 0 |
| muscle | 95% | 468.09 | 766 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 76% | 725.64 | 710 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0106074 | Biological process | aminoacyl-tRNA metabolism involved in translational fidelity |
| GO_0006419 | Biological process | alanyl-tRNA aminoacylation |
| GO_0070143 | Biological process | mitochondrial alanyl-tRNA aminoacylation |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0000049 | Molecular function | tRNA binding |
| GO_0002161 | Molecular function | aminoacyl-tRNA editing activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004813 | Molecular function | alanine-tRNA ligase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | AARS2 |
| Protein name | Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) AARS2 protein |
| Synonyms | KIAA1270 AARSL |
| Description | FUNCTION: Catalyzes the attachment of alanine to tRNA(Ala) in a two-step reaction: alanine is first activated by ATP to form Ala-AMP and then transferred to the acceptor end of tRNA(Ala). Also edits incorrectly charged tRNA(Ala) via its editing domain. . |
| Accessions | A2VCL8 ENST00000244571.5 Q5JTZ9 |